1
|
Bertoni L, Barresi V, Bonetti LR, Caramaschi S, Mangogna A, Lionti S, Azzoni P, Carnevale G, Pisciotta A, Salviato T. Poorly differentiated clusters (PDC) in colorectal cancer: Does their localization in tumor matter? Ann Diagn Pathol 2019; 41:106-111. [DOI: 10.1016/j.anndiagpath.2019.06.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2019] [Revised: 06/07/2019] [Accepted: 06/15/2019] [Indexed: 02/07/2023]
|
2
|
Barresi V, Lionti S, La Rocca L, Caliri S, Caffo M. High p-mTOR expression is associated with recurrence and shorter disease-free survival in atypical meningiomas. Neuropathology 2018; 39:22-29. [PMID: 30511495 DOI: 10.1111/neup.12524] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2018] [Revised: 10/06/2018] [Accepted: 10/06/2018] [Indexed: 01/15/2023]
Abstract
Due to their widely variable clinical behavior, the post-surgical treatment of atypical meningiomas is controversial. Therefore, prognostic factors able to identify high-risk cases, which may benefit from adjuvant treatments, are warranted. Mammalian target of rapamycin (mTOR) belongs to the PI3K-AKT pathway. Its phosphorylated form (p-mTOR Ser2448) is involved in cell growth, differentiation and tumorigenesis. The aim of this study was to evaluate p-mTOR Ser2448 expression and its eventual correlation with clinicopathological features, recurrence, or disease-free survival (DFS), in atypical meningiomas. p-mTOR immunohistochemical expression was analyzed in 48 atypical meningiomas and correlated with clinicopathological parameters and with DFS. Eighty-one percent of atypical meningiomas expressed p-mTOR Ser2448. High immuno-expression was significantly associated with recurrences (P = 0.01) and lower DFS (P = 0.01). The presence of brain invasion, high mitotic index plus sheeting, and Simpson grade were significant and independent prognostic variables at multivariate analysis. p-mTOR Ser2448 is expressed in atypical meningiomas. High expression predicts development of recurrences and shorter DFS in patients affected by these tumors. Since p-mTOR Ser2448 is a target of anti-neoplastic drugs, evaluation of its expression may be used, not only to identify atypical meningiomas at higher risk of recurrence, but also to select those to submit to adjuvant targeted chemotherapy.
Collapse
Affiliation(s)
- Valeria Barresi
- Departments of Pathology in Adulthood and Evolutive Age, University of Messina, Messina, Italy
| | - Simona Lionti
- Departments of Pathology in Adulthood and Evolutive Age, University of Messina, Messina, Italy
| | - Lilli La Rocca
- Departments of Pathology in Adulthood and Evolutive Age, University of Messina, Messina, Italy
| | - Samuel Caliri
- Departments of Pathology in Adulthood and Evolutive Age, University of Messina, Messina, Italy
| | - Maria Caffo
- Biomedical and Odontoiatric Sciences, and of Morphological and Functional Images, University of Messina, Messina, Italy
| |
Collapse
|
3
|
Lionti S, La Rocca L, Nunnari CM, Barresi V. Strong androgen receptor expression is not useful in distinguishing GATA3 + metastases. Pathol Res Pract 2018; 214:2110-2114. [PMID: 30293951 DOI: 10.1016/j.prp.2018.09.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2018] [Revised: 09/15/2018] [Accepted: 09/28/2018] [Indexed: 01/27/2023]
Abstract
GATA binding protein 3 (GATA3) immunohistochemical expression is commonly considered to be a sensitive and specific diagnostic marker for breast and urothelial carcinomas in surgical pathology practice. However, since its expression has been also demonstrated in other tumors, GATA3 should be better used in conjunction with other immunohistochemical markers to establish tumor primitivity in metastatic setting. Interestingly, GATA3 expression seems to be significantly correlated with androgen receptor (AR) expression in breast carcinoma. In addition, strong AR expression -defined as immunohistochemical positivity in more than 60% of tumor cells- was suggested to be 100% specific for breast origin in GATA3+ metastases. The aim of this study was to verify whether strong AR expression may actually be useful to determine primivity in GATA3+ metastatic setting. Thus, we investigated AR and GATA3 immuno-expression in a cohort of metastatic tumors derived from urothelial, breast, endometrial and salivary gland carcinomas. We did not find any GATA3 or AR expression in the metastases from endometrial or salivary gland carcinomas, while GATA3 expression was seen in the majority of metastases from urothelial or breast carcinomas. In addition, strong AR expression was seen in 73% and in 47% of metastatic breast and urothelial carcinomas, respectively. On the whole, our findings confirm that GATA3 is sensitive and specific for breast and urothelial origin in metastatic setting. According to our results, strong AR expression is not useful to distinguish breast from urothelial primitivity, as previously suggested.
Collapse
Affiliation(s)
- Simona Lionti
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", Università di Messina, Italy
| | - Lilli La Rocca
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", Università di Messina, Italy
| | - Carmela Mirella Nunnari
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", Università di Messina, Italy
| | - Valeria Barresi
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", Università di Messina, Italy.
| |
Collapse
|
4
|
Barresi V, Nunnari CM, Lionti S. Immunohistochemical stains to detect residual tumor in cystectomy specimens taken shortly after transurethral resection of bladder tumors. Ann Diagn Pathol 2018; 40:176-179. [PMID: 30266536 DOI: 10.1016/j.anndiagpath.2018.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Revised: 09/09/2018] [Accepted: 09/20/2018] [Indexed: 10/28/2022]
Affiliation(s)
- Valeria Barresi
- Department of Human Pathology, University of Messina, Italy.
| | | | - Simona Lionti
- Department of Human Pathology, University of Messina, Italy
| |
Collapse
|
5
|
Barresi V, Lionti S, Bonetti LR. Poorly differentiated clusters in colorectal liver metastases: Prognostic significance in synchronous and metachronous metastases. J Surg Oncol 2018; 117:1856-1857. [DOI: 10.1002/jso.25077] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2018] [Accepted: 03/13/2018] [Indexed: 01/09/2023]
Affiliation(s)
- Valeria Barresi
- Department of Pathology in Evolutive Age and Adulthood “Gaetano Barresi”; University of Messina; Messina Italy
| | - Simona Lionti
- Department of Pathology in Evolutive Age and Adulthood “Gaetano Barresi”; University of Messina; Messina Italy
| | - Luca Reggiani Bonetti
- Department of Laboratory Integrated Activities; Anatomic Pathology and Legal Medicine; University of Modena and Reggio Emilia; Modena Italy
| |
Collapse
|
6
|
Lionti S, Ieni A, Cannavò S, Barresi V. Immunohistochemical expression of glypican-3 in adrenocortical carcinoma: A potential cause of diagnostic pitfalls. Ann Diagn Pathol 2018; 35:92-93. [PMID: 29748062 DOI: 10.1016/j.anndiagpath.2018.05.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Revised: 04/18/2018] [Accepted: 05/02/2018] [Indexed: 10/25/2022]
Affiliation(s)
- Simona Lionti
- Department of Human Pathology, University of Messina, Italy
| | - Antonio Ieni
- Department of Human Pathology, University of Messina, Italy
| | | | - Valeria Barresi
- Department of Human Pathology, University of Messina, Italy.
| |
Collapse
|
7
|
Lionti S, Reggiani Bonetti L, Bettelli S, Spallanzani A, Gelsomino F, Barresi V. Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters. Hum Pathol 2018; 78:115-124. [PMID: 29715463 DOI: 10.1016/j.humpath.2018.04.019] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Revised: 04/08/2018] [Accepted: 04/12/2018] [Indexed: 02/07/2023]
Abstract
The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical variables or on the anatomic extent of colorectal cancer (CRC). Histopathological factors of LMs which may actually reflect the biological aggressiveness of the tumor are not routinely considered to define the risk of worse clinical outcome in those patients. The number of poorly differentiated clusters (PDCs) of neoplastic cells in primary CRC is associated with metastatic risk and bad prognosis, but PDC presence in LMs has been barely analyzed thus far. We assessed PDC presence in the histological slides of surgically resected and synchronous LMs in 63 patients with CRC who had been not submitted to any neoadjuvant treatments. Then, we analyzed its association with patients' cancer-specific survival (CSS) or progression-free survival. The presence of PDCs (P = .016) and PDC localization at tumor edge of LMs (P = .0004) were significantly associated with shorter CSS. PDC presence at the periphery of LMs and positive resection margin were independent prognostic variables for CSS. PDC localization at the tumor edge of LMs was a significant (P = .0079) and independent prognosticator of shorter progression-free survival. Our data suggest that PDC presence and peripheral localization in LMs may be relevant to predict outcome and useful for clinical decision making in patients with colorectal synchronous LMs.
Collapse
Affiliation(s)
- Simona Lionti
- Department of Pathology in Evolutive Age and Adulthood "Gaetano Barresi," University of Messina, 98125, Messina, Italy
| | - Luca Reggiani Bonetti
- Department of Laboratory Integrated Activities, Anatomic Pathology and Legal Medicine, University of Modena and Reggio Emilia, 41125, Modena, Italy
| | - Stefania Bettelli
- Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, 41124, Modena, Italy
| | - Andrea Spallanzani
- Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, 41124, Modena, Italy
| | - Fabio Gelsomino
- Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, 41124, Modena, Italy
| | - Valeria Barresi
- Department of Pathology in Evolutive Age and Adulthood "Gaetano Barresi," University of Messina, 98125, Messina, Italy.
| |
Collapse
|
8
|
Barresi V, Lionti S, Caliri S, Caffo M. Histopathological features to define atypical meningioma: What does really matter for prognosis? Brain Tumor Pathol 2018; 35:168-180. [PMID: 29671247 DOI: 10.1007/s10014-018-0318-z] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Accepted: 04/12/2018] [Indexed: 12/18/2022]
Abstract
Atypical meningiomas are diagnosed in the presence of: (1) three or more of the following minor atypical criteria: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, sheeting, and foci of spontaneous or geographic necrosis; (2) mitotic count ≥ 4 mitoses per 10 HPF (high mitotic index); (3) brain invasion. The 5-year disease-free survival (DFS) is around 50%. Due to their heterogeneous behavior, the post-surgical treatment of atypical meningiomas is controversial. This study investigated the ability of histopathological features to predict recurrence risk of atypical meningiomas. Meningiomas classified as atypical only on minor atypical criteria had low recurrence risk. Brain invasion, high mitotic index and sheeting were significantly associated with shorter disease-free survival (DFS) (P = 0.001; P = 0.01; P = 0.01). The presence of brain invasion and the co-presence of sheeting and high mitotic index had the highest ability to identify recurring meningiomas (P = 0.0001) (sensitivity: 90.9%; specificity: 86.7%). Our results suggest reconsideration of classification of meningiomas as atypical based only on minor atypical criteria. The presence of brain invasion and the co-occurrence of sheeting and high mitotic count may be useful to identify high risk cases, which may benefit from adjuvant treatments.
Collapse
Affiliation(s)
- Valeria Barresi
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", AOU Policlinico G. Martino, Pad D, University of Messina, Via Consolare Valeria, 98125, Messina, Italy.
| | - Simona Lionti
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", AOU Policlinico G. Martino, Pad D, University of Messina, Via Consolare Valeria, 98125, Messina, Italy
| | - Samuel Caliri
- Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva "G. Barresi", AOU Policlinico G. Martino, Pad D, University of Messina, Via Consolare Valeria, 98125, Messina, Italy
| | - Maria Caffo
- Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali, University of Messina, Messina, Italy
| |
Collapse
|
9
|
Barresi V, Lionti S, Raso A, Esposito F, Cannavò S, Angileri FF. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description. Neuropathology 2017; 38:260-267. [DOI: 10.1111/neup.12440] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2017] [Revised: 10/04/2017] [Accepted: 10/04/2017] [Indexed: 12/14/2022]
Affiliation(s)
- Valeria Barresi
- Department of Human Pathology in Adulthood and Evolutive Age; University of Messina; Messina Italy
| | - Simona Lionti
- Department of Human Pathology in Adulthood and Evolutive Age; University of Messina; Messina Italy
| | - Alessandro Raso
- Unit of Neurosurgery; Giannina Gaslini Institute; Genoa Italy
| | - Felice Esposito
- Unit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging; University of Messina; Messina Italy
| | - Salvatore Cannavò
- Department of Human Pathology in Adulthood and Evolutive Age; University of Messina; Messina Italy
| | - Filippo F. Angileri
- Unit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging; University of Messina; Messina Italy
| |
Collapse
|
10
|
Reggiani Bonetti L, Lionti S, Vitarelli E, Barresi V. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma. Virchows Arch 2017; 471:731-741. [PMID: 28819729 DOI: 10.1007/s00428-017-2219-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2017] [Revised: 08/01/2017] [Accepted: 08/09/2017] [Indexed: 12/26/2022]
Abstract
CDX2 is a transcription factor that acts as a tumor suppressor in colorectal cancer (CRC). Its loss triggers metastatic process and tumor progression; however, its prognostic role in patients with CRC is still controversial. Poorly differentiated clusters (PDCs) are aggregates of neoplastic cells which likely have high metastatic potential in CRC. In this study, we analyzed and compared CDX2 expression in PDC (CDX2-PDC) and corresponding main tumor (CDX2 main tumor) in 42 CRCs showing at least 10 PDC (PDC G3). Five of 42 CRCs (12%) were classified as CDX2 main tumor negative (4/5 were also PDC-CDX2 negative); all had tumor recurrence and died of CRC. Twenty nine of 42 cases were CDX2-PDC negative. Among CRC CDX2 main tumor positive, 15 had recurrences and 13 died from CRC; 13 and 11 of them, respectively, were CDX2-PDC negative. By assigning one point to CDX2 main tumor or CDX2-PDC positivity, we assessed CDX2-staining score for each case. Twelve cases had CDX2-staining score 2 (CDX2 positive in main tumor and PDC); 26 had score 1 (CDX2 positive in main tumor or PDC), and 4 had CDX2 score 0 (CDX2 negative in main tumor and PDC). In our patients, CDX2-staining score had higher prognostic value compared to CDX2 main tumor or CDX2-PDC alone. In addition, it represented a significant and independent prognostic variable for disease-free survival (DFS) and cancer-specific survival (CSS). Our findings suggest that, although loss of CDX2 in the main tumor identifies high-risk patients with high specificity, CDX2-PDC should also be considered in CDX2 main tumor positive cases to predict prognosis.
Collapse
Affiliation(s)
- Luca Reggiani Bonetti
- Department of Laboratory Integrated Activities, Anatomic Pathology and Legal Medicine, University of Modena and Reggio Emilia, Modena, Italy
| | - Simona Lionti
- Department of Pathology in Evolutive Age and Adulthood "Gaetano Barresi", University of Messina, Polyclinic G. Martino, Pad D, Via Consolare Valeria, 98125, Messina, Italy
| | - Enrica Vitarelli
- Department of Pathology in Evolutive Age and Adulthood "Gaetano Barresi", University of Messina, Polyclinic G. Martino, Pad D, Via Consolare Valeria, 98125, Messina, Italy
| | - Valeria Barresi
- Department of Pathology in Evolutive Age and Adulthood "Gaetano Barresi", University of Messina, Polyclinic G. Martino, Pad D, Via Consolare Valeria, 98125, Messina, Italy.
| |
Collapse
|
11
|
Reggiani Bonetti L, Lionti S, Domati F, Pagliani G, Mattioli E, Barresi V. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy. Histopathology 2017; 71:393-405. [DOI: 10.1111/his.13242] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2017] [Revised: 04/11/2017] [Accepted: 04/16/2017] [Indexed: 02/06/2023]
Affiliation(s)
- Luca Reggiani Bonetti
- Department of Laboratory Integrated Activities, Anatomical Pathology and Legal Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - Simona Lionti
- Department of Pathology in Evolutive Age and Adulthood ‘Gaetano Barresi’; University of Messina; Messina Italy
| | - Federica Domati
- Department of Laboratory Integrated Activities, Anatomical Pathology and Legal Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - Giuliana Pagliani
- Department of Laboratory Integrated Activities, Anatomical Pathology and Legal Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - Elisabetta Mattioli
- Department of Laboratory Integrated Activities, Anatomical Pathology and Legal Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - Valeria Barresi
- Department of Pathology in Evolutive Age and Adulthood ‘Gaetano Barresi’; University of Messina; Messina Italy
| |
Collapse
|
12
|
Barresi V, Lionti S, Valori L, Gallina G, Caffo M, Rossi S. Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity? J Neuropathol Exp Neurol 2017; 76:342-346. [DOI: 10.1093/jnen/nlx024] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
|
13
|
Reggiani Bonetti L, Lionti S, Domati F, Barresi V. Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery? World J Gastroenterol 2017; 23:1412-1423. [PMID: 28293088 PMCID: PMC5330826 DOI: 10.3748/wjg.v23.i8.1412] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/22/2016] [Revised: 12/29/2016] [Accepted: 01/17/2017] [Indexed: 02/06/2023] Open
Abstract
AIM To clarify which factors may influence pathological tumor response and affect clinical outcomes in patients with locally advanced rectal carcinoma treated with neo-adjuvant chemoradiotherapy and surgery.
METHODS Tumor regression grade (TRG) according to the Dworak system and yTNM stage were assessed and correlated with pre-treatment clinico-pathological variables in 215 clinically locally advanced (cTNM stage II and III) rectal carcinomas. Prognostic value of all pathological and clinical factors on disease free survival (DFS) and cancer specific survival (CSS) was analyzed by Kaplan Meier and Cox-regression analyses.
RESULTS cN+ status, mucinous histotype or poor differentiation in the pre-treatment biopsy were significantly associated with lower pathological response (low Dworak grade and TNM remaining unchanged/upstaging). Cases showing acellular mucin pools in surgical specimens all had unremarkable clinical courses with no deaths or recurrences during follow-up. Dworak grade had prognostic significance for DFS and CSS. However, compared to the 5-tiered system, a simplified two-tiered grading system, in which grades 0, 1 and 2 were grouped as absent/partial regression and grades 3 and 4 were grouped as total/subtotal regression, was more reproducible and prognostically informative. The two-tiered Dworak system, yN stage, craniocaudal extension of the tumor and radial margin status were significant independent prognostic variables.
CONCLUSION Our data suggest that caution should be applied in using a conservative approach in rectal carcinomas with cN+ status, extensive/lower involvement of the rectum and mucinous histotype or poor differentiation. Although Dworak TRG is prognostically significant, a simplified two-tiered system could be preferable. Finally, cases with acellular mucin pools should be carefully evaluated to definitely exclude residual mucinous carcinoma.
Collapse
|
14
|
Barresi V, Lionti S, Messina E, Esposito F, Angileri FF, Cannavò S. A 53-year-old woman with Cushing's disease and a pituitary tumor. Neuropathology 2016; 37:86-90. [DOI: 10.1111/neup.12319] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Revised: 05/20/2016] [Accepted: 05/22/2016] [Indexed: 11/26/2022]
Affiliation(s)
- Valeria Barresi
- Dipartimento di Patologia Umana dell'Adulto e dell'età evolutiva “G. Barresi”; Università di Messina; Italy
| | - Simona Lionti
- Dipartimento di Patologia Umana dell'Adulto e dell'età evolutiva “G. Barresi”; Università di Messina; Italy
| | - Erika Messina
- Dipartimento di Medicina Clinica e Sperimentale; Università di Messina; Italy
| | - Felice Esposito
- Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali; Università di Messina; Italy
| | - Filippo Flavio Angileri
- Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali; Università di Messina; Italy
| | - Salvatore Cannavò
- Dipartimento di Medicina Clinica e Sperimentale; Università di Messina; Italy
| |
Collapse
|